A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread

Clinical trial NCT01395121 · COMPLETED

Trial details

NCT number: NCT01395121
Sponsor: Institute of Cancer Research, United Kingdom
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mucosal Lentiginous Melanoma Acral Lentiginous Malignant Melanoma

Start date: 2009-12-01
Primary completion: 2016-12-12
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.